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Abstract
Background:  Uterine cervix carcinoma is the second most common female malignancy
worldwide and a major health problem in Mexico, representing the primary cause of death among
the Mexican female population. High risk human papillomavirus (HPV) infection is considered to be
the most important risk factor for the development of this tumor and cervical carcinoma derived
cell lines are very useful models for the study of viral carcinogenesis. Comparative Genomic
Hybridization (CGH) experiments have detected a specific pattern of chromosomal imbalances
during cervical cancer progression, indicating chromosomal regions that might contain genes that
are important for cervical transformation.
Methods: We performed HPV detection and CGH analysis in order to initiate the genomic
characterization of four recently established cervical carcinoma derived cell lines from Mexican
patients.
Results: All the cell lines were HPV18 positive. The most prevalent imbalances in the cell lines
were gains in chromosomes 1q23-q32, 3q11.2-q13.1, 3q22-q26.1, 5p15.1-p11.2, this alteration
present as a high copy number amplification in three of the cell lines, 7p15-p13, 7q21, 7q31, 11q21,
and 12q12, and losses in 2q35-qter, 4p16, 6q26-qter, 9q34 and 19q13.2-qter.
Conclusions: Analysis of our present findings and previously reported data suggest that gains at
1q31-q32 and 7p13-p14, as well as losses at 6q26-q27 are alterations that might be unique for
HPV18 positive cases. These chromosomal regions, as well as regions with high copy number
amplifications, coincide with known fragile sites and known HPV integration sites. The general
pattern of chromosomal imbalances detected in the cells resembled that found in invasive cervical
tumors, suggesting that the cells represent good models for the study of cervical carcinoma.
Background
Cervical carcinoma stands as the first cause of death
among the Mexican female population with 14 deaths per
100,000 women with 15 years old or more, representing
34.2 % of all new female cancer cases reported [1]. High
risk human papillomavirus (HPV) infection is considered
to be the most important risk factor associated with the
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development of this tumor, and is present in 99.7% of the
invasive cervical tumors worldwide [2].
Comparative Genomic Hybridization (CGH) is a method
employed in cancer genomics that allows the detection of
DNA gains or losses at the genome level in a single hybrid-
ization experiment, indicating cytogenetic regions that
might be involved in the transformation process. CGH
has detected a specific pattern of chromosomal imbalanc-
es associated with particular stages of cervical transforma-
tion, and with different biological behaviors [3–10]. In
this paper, we evaluated the presence of HPV DNA and
analyzed the pattern of chromosomal imbalances using
CGH in four cell lines established from tumor explants of
Mexican patients. The establishment and research use of
two of these cell lines has been previously reported
[11,12]. Further genomic characterization of these lines
will open new possibilities for understanding cervical car-
cinoma, since the coincidence between the chromosomal
imbalances present in these cell lines and patterns found
in cervical tumors indicate that they are good models for
the study of cervical cancer.
Methods
The cell lines were established from stages IIA and IVA sq-
uamous cell cervical carcinoma explants from Mexican fe-
males (Table 1) at the National University of Mexico, as
previously described [11,12]. Cell lines were designated
CALO, INBL, VIPA and ROVA.
HPV detection was done using the L1 consensus primers
MY09/MY11. After denaturation at 94°C for 5 minutes,
100 ng of DNA were subjected to 40 cycles of 94°C for 1
min, 55°C for 2 min and 73°C for 3 min, with a final ex-
tension step of 7 min at 72°C. The amplicon was labeled
using the Big Dye kit (Applied Biosystems, Foster City,
CA) and sequenced with an ABI 373 automated sequenc-
er. BLAST sequence comparison was done in order to
know the HPV type.
All CGH procedures were performed using reagents and
kits from Vysis Inc. (Downers Grove, IL), following the
manufacturer's instructions. Cell line DNA was labeled
using the CGH nick translation kit, and the hybridization
mixture was prepared according to the CGH reagent kit,
consisting of 200 ng of spectrum-green labeled cell line
DNA, 100 ng of spectrum-red labeled normal male refer-
ence DNA and 20 µg of human Cot-1 DNA. Hybridization
was performed over 3 days at 37°C on normal male met-
aphase spreads (Vysis, Downers Grove, IL).
Digital images were collected using the Smart Capture
(Vysis) software with a charged coupled device camera
mounted on an epifluorescence microscope. An average
of 15 metaphases per case were analysed using the Vysis
Table 1: Chromosomal imbalances detected in hpv18 positive cell lines
Cell line Tumor stage DNA Losses DNA Gains Total
CALO II-B 1pter-p32, 2q35-qter, 4pter-p15.2, 4q32-qter, 5q33-
qter, 6q24-qter, 8pter-p22, 8q24.2-qter, 9q32-qter, 
11q12, 12p13, 12q22-qter, 13q12, 15q11.2-q12, 
16p, 16q22-qter, 17, 18q11, 19, 20, 21, 22. 
Total:21
1p31-p12, 1q22-q31, 2p15, 2q21-q32, 3p22, 
3q11.2-q26.3, 4q26-q31.2, 5p, 5q11.2-q23, 6q22, 
7p15-p12, 7q21-q31, 9p23-p21, 11q14-q22, 
12p11.2, 12q15-q21, 13q21-q31, 18q12. Total: 18
39
VIPA II-A 1p32-pter, 2p24, 2q35-qter, 4p15.3-pter, 4q33-qter, 
5q33-qter, 6q25-qter, 7p22, 7q33 qter, 8p21-pter, 
9q32-qter, 10p13-pter, 10q24-qter, 11q12, 12p13, 
12q22-qter, 14q31-qter, 16p, 16q13-qter, 17, 
18q22, 19, 20p13, 20q, 21q22, 22. Total:26
1p12-p22, 1q23-q32, 2q21-q32.3, 3p22, 3p13-p12, 
3q13.1-q13.3, 3q22-q25, 4q13, 4q22-q31.3, 5p, 
5q11.2-q12, 5q14-q23, 6p12-p21.1, 6q12-q16, 
7p12-p21, 7q21-q31, 8q21.1-q22, 9p21-p22, 
10q21, 11p13, 11q14-q22, 12p11.2, 12q14-q21, 
13q 14-q31, 14q12-q13, 15q21. Total: 26
52
INBL IV-A 2q34-qter, 4p, 4q32-qter, 6q24-qter, 8p22, 13q12, 
18p21-pter, 19p13.2-pter. Total: 8
1q12-q41, 3q12-q26.3, 5p, 6p24-p22, 6p21.1-
p11.1, 7p14-p11.1, 7q21-q31, 11p15, 11q21, 
12q12, 15q22-q24. Total: 11
19
ROVA IV-A 1p35-pter, 2p25, 2q35-qter, 3q29-qter, 4p16, 5q35, 
6q26-qter, 7p22, 8p23, 8q24.1-qter, 9q33-qter, 
10q26, 12p13, 12q24.1-qter, 16p, 16q22-qter, 
17p12-pter, 17q23-qter, 18q22-qter, 19, 20q13.1-
qter, 21q22, 22q. Total: 23
1p12-p31, 1q22-q32, 2p11.2-p16, 2q21-q33, 3p12-
p22, 3q13.1-q26.3, 4p12-p15.2, 4q12-q31.3, 5p12-
p15.1, 5q11.2-q31, 6p22-p23, 6p12-p, 6q12-q15, 
6q22, 7p12-p15, 7q21-q31, 8p22, 8q13, 9p21-p23, 
9q21, 11p14, 11q14-q24, 12p12, 12q12-q21, 
13q14-q31, 14q11.2-q24, 15q15-q21, 15q24, 
18q11.2-q12. Total: 28
51
Average 19.5 20.7 ANCA:40.2
All tumors were diagnosed as squamous cell carcinomas. ANCA: Average Number of Chromosomal Aberrations, obtained dividing the total 
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CGH software using a >1.2 ratio threshold for detecting
DNA gains and <0.8 for losses, these thresholds were cho-
sen based on previous normal VS. normal hybridizations.
Sex chromosomes and heterochromatic areas (centromer-
ic and paracentromeric regions of chromosomes 1, 9, 16,
p arms of acrocentric chromosomes) were excluded from
the analysis. A "reverse painting" experiment was used as
a control for the CGH results. CGH data from the cell lines
is available at the NCI and NCBI Spectral Karyotyping
(SKI) and CGH Database http://www.ncbi.nlm.nih.gov/
sky/skyweb.cgi.
Results and Discussion
HPV DNA was detected in all the cell lines. Sequence anal-
ysis identified HPV18 in all the samples. All the cell lines
presented chromosomal imbalances. A line summary ide-
ogram of the chromosomal imbalances in the cell lines is
presented in Figure 1. A complete description of the im-
balances detected in each cell line is presented in Table 1.
On the average, 19.5 DNA losses and 20.7 gains were de-
tected in the samples, with an average number of chromo-
somal aberrations of 40.2 alterations per case, ranging
from 52 alterations in VIPA to 19 alterations in INBL. The
most prevalent imbalances were gains in chromosomes
1q23-q32, 3q11.2-q13.1, 3q22-q26.1, 5p15.1-p11.2. This
alteration is present as a high copy number amplification
in three of the cell lines, 7p15-p13, 7q21, 7q31, 11q21,
and 12q12, and losses in 2q35-qter, 4p16, 6q26-qter,
9q34 and 19q13.2-qter. Comparison between chromo-
somal imbalances in these cell lines and those found in
cervical tumors; indicate the presence of common genetic
alterations, suggesting that they represent their tissue of
origin. These common regions include gains in 3q22-
q26.2 and 5p, and losses on 2q35-qter, 4q32-qter and
18q. Some of these alterations have been detected in early
stages of cervical transformation and are conserved in ad-
vanced tumors or have been associated with the presence
of metastases and with a worse clinical behavior [6,7,10],
making the cells good models for the study of genes in-
volved in the maintenance of the transformed phenotype.
Compared with the imbalances previously found on
HPV18 positive cases [9], there is coincidence for the DNA
gains at 1q31-q32, 3q22-q26.3, 5p14 and 7p13-p14, as
well as in DNA losses at 2q33-qter and 6q26-q27. Differ-
ences among the cell lines and data from invasive cervical
tumors were also found. For example, we did not find de-
letions of 3p or 11q regions in the cell lines. This situation
might be explained by the enrichment or selection of a
particular cell clone during the cell line establishment.
A common observation in uterine cervix carcinomas is the
integration of HPV DNA into the cellular genome. How-
ever, the consequences of this integration event are only
poorly understood. Differences in the frequency of
HPV18 and HPV16 integration have been detected, 72%
of the HPV16 tumors presented viral integration, while
HPV18 positive tumors had viral integration in 100% of
the cases [13,14]. This is a possible explanation for the ob-
served HPV18 incidence in the studied cell lines, since the
integration event might represent a growth advantage for
the cell in culture. Analysis of our present findings and
previously reported data suggest that gains at 1q31-q32
and 7p13-p14, as well as losses at 6q26-q27 are altera-
tions that are unique for HPV18 positive cases. HPV inte-
gration at the 1q31-q32 has been found in nasal epithelial
cells immortalized with HPV16 DNA and also contains
the short tandem repeat region F13B [15]. The NEK7 (NI-
MA (never in mitosis gene a)-related kinase 7, 1q31.3)
gene is located in this region and plays an important role
in the control of mitosis initiation [16]. The role of this
gene in human cancer has not been explored. Regarding
the 7p15-p13 region, a lymphocyte fragile site has been
detected at 7p13, high copy number amplification of this
region was also found by us in primary cervical carcino-
mas [9] and gain of 7p was also found in HPV transfected
cells during the immortalization process [4]. The PE5L
gene, (7p13-p14) presents a sequence homology with the
HPV18 E5 gene, making this gene a possible target for re-
combination and viral integration [17]. However, align-
ment of the PE5L sequence against the November 2002
freeze of the Human Genome working draft, showed the
best matching score on 7p11.2 (not shown). The public
availability of viral-cellular fusion transcripts or DNA se-
quences, combined with data from the human genome,
will certainly help to better define areas of viral integra-
tion for further investigation.
The lost cytogenetic region 6q26 comprises the fragile site
FRA6E, the third most frequently observed common frag-
ile site. Deletion of the 6q26-q27 region has been found
in approximately 44% of all tumor types analyzed by
CGH [18], and in cervical carcinoma loss of heterozigosity
was found 39% of the cases [19]. An interesting gene lo-
cated in this region is the mitogen-activated protein ki-
nase kinase kinase 4 (MAP3K4), a major mediator of
environmental stresses that activate the CSBP2 MAPK
pathway, which, in turn, regulates the expression of TNF
and several cytokines, and controls the initiation of the
G2/M checkpoint after UV radiation [20].
We also found high copy number amplifications in re-
gions 7q21, 7q31, 11q21 and 11q12. Region 7q21 con-
tains the rare, folic acid type FRA7E fragile site and a
cellular-HPV fusion transcript has been detected at this ar-
ea, with no sequence match to a known gene [21]. 7q31
has been reported to be the site of a chromosomal break-
point in cervical carcinoma cell lines [22] and contains the
c-Met oncogene, whose over-expression has been correlat-
ed to the diameter of the primary tumor, deep cervical
stromal invasion, presence of metastatic lymph node andBMC Cancer 2003, 3 http://www.biomedcentral.com/1471-2407/3/8
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number of metastatic lymph nodes [23]. The 11q21-q22
region was also found in our cell lines, this region has
been found amplified in some cervical carcinoma cell
lines and over-expression of the cIAP1 gene, an apoptosis
inhibitor and possible target of the amplification, was re-
lated to a poorer overall survival and local recurrence-free
survival in cervical carcinoma [24].
It is interesting to notice that almost all of the possible
HPV18 related sites of chromosomal imbalance, as well as
the regions with high copy number amplifications in our
cell lines correspond to the location of fragile sites in the
human genome. Since HPV integration preferentially
seems to target these kind of fragile sites, it is possible that
HPV18 is integrated into these altered chromosomal re-
gions in our cell lines. Recently, a comprehensive charac-
terization of cervical cancer cell lines gave very useful
information about specific chromosomal alterations,
DNA gains, losses and clusters of chromosome break-
points in cervical cancer cell lines and their relation to
HPV presence and integration [24]. Currently, such a char-
acterization of our newly established cell lines is being
carried out.
Conclusions
High throughput genetic analysis often require vast
amounts of tissue that sometimes is not available, making
the cell lines the model of choice to overcome this prob-
lem. Here, we report the presence of HPV18 and the pat-
tern of chromosomal imbalances detected in four newly
established uterine cervix carcinoma derived cell lines.
The pattern of genetic imbalances in these cell lines sug-
Figure 1
CGH ideograms of the genetic imbalances detected in the cell lines. The lines at the right of the chromosome ideogram repre-
sent DNA gains, lines at the left, DNA losses. Thick lines represent high copy number amplifications or multi copy deletions 
(ratio >1.4 or <0.6). The mark closest to the ideogram represents the cell lines CALO, followed by VIPA, INBL and ROVA.
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gest that they represent good models for cervical carcino-
ma and HPV18 infection, providing another useful
cellular model for the discovery and functional analysis of
genomic alterations involved in cervical cancer when this
viral type is present.
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